Track the 제놀루션 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 제놀루션 has published 10 public disclosures. Market capitalisation: €24.7bn. The latest transaction was reported on 30 June 2026 (Purchase). Among the most active insiders: 김민이. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
10 of 10 declarations
Genolution es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se enfoca en desarrollar soluciones innovadoras para mejorar la atención médica.